Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancerOlivia D. Lara, Anil K. Sood|Oncotarget|2020Cited by 10
SPL-108 mitigates metastasis and chemoresistance in tubo-ovarian carcinomaOlivia D. Lara, Kari Hacker|Translational Oncology|2024Cited by 1
Evaluating the therapeutic efficacy of Grb2 inhibition in ovarian malignanciesOlivia D. Lara|Digital Commons-TMC (Texas Medical Center)|2019Cited by 0